OM
Outset Medical, Inc.
+0.01 (+0.32%)3.13USD31.6K成交股數58.8M市值–本益比(近四季)0.5股價營收比+0.7%營收年增(近四季)2026-11-09下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 31.6M+6% | 27.9M-5% | 29.4M+3% | 31.4M+15% | 29.8M+6% | 29.5M-3% | 28.7M-20% | 27.4M-18% | 28.2M | 30.4M | 36.0M | 33.5M |
| 營業成本 | 18.4M | 15.8M | 17.8M | 19.6M | 18.7M | 18.7M | 18.8M | 17.6M | 20.0M | 23.2M | 28.3M | 27.0M |
| 毛利 | 13.3M+20% | 12.1M+13% | 11.6M+18% | 11.9M+21% | 11.1M+35% | 10.7M+50% | 9.8M+27% | 9.8M+52% | 8.2M | 7.2M | 7.7M | 6.4M |
| 毛利率 | 42.0% | 43.4% | 39.4% | 37.8% | 37.2% | 36.5% | 34.3% | 35.7% | 29.2% | 23.6% | 21.4% | 19.2% |
| 研發費用 | 5.5M | 5.6M | 5.4M | 5.3M | 5.5M | 7.9M | 8.1M | 9.7M | 12.6M | 16.1M | 14.9M | 13.8M |
| 銷售管理費用 | 11.4M | 10.1M | 8.5M | 9.2M | 8.3M | 9.3M | 10.1M | 12.7M | 11.4M | 11.8M | 11.3M | 11.8M |
| 營業利益 | −15.7M-4% | −16.9M-23% | −15.8M-34% | −16.9M-45% | −16.4M-56% | −21.9M-52% | −23.8M-45% | −30.8M-29% | −36.9M | −45.5M | −43.5M | −43.5M |
| 營業利益率 | -49.6% | -60.7% | -53.7% | -53.7% | -55.1% | -74.2% | -83.2% | -112.3% | -131.0% | -149.7% | -120.6% | -129.9% |
| 稅後淨利 | −18.0M-30% | −19.0M-26% | −17.8M-36% | −18.5M-46% | −25.8M-35% | −25.6M-44% | −27.9M-37% | −34.5M-22% | −39.9M | −46.2M | −44.0M | −44.0M |
| 淨利率 | -56.8% | -68.1% | -60.6% | -59.0% | -86.7% | -87.0% | -97.5% | -125.8% | -141.8% | -152.1% | -122.2% | -131.4% |
| 稀釋 EPS | -0.97-73% | -1.03-86% | -1.00-88% | -1.04-90% | -3.66-69% | -7.21+675% | -8.02+791% | -9.96+1007% | -11.77 | -0.93 | -0.90 | -0.90 |
| 稀釋股數 | 18.6K | 18.4K | 17.8K | 17.7K | 7.0K | 3.5K | 3.5K | 3.5K | 3.4K | 49.9K | 49.0K | 48.8K |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 35.0M | 30.6M | 36.4M | 39.6M | 75.9M | 124M | 33.3M | 37.9M | 32.2M | 36.3M | 36.4M | 36.4M |
| 應收帳款 | 29.2M | 25.3M | 33.0M | 34.9M | 36.9M | 35.6M | 34.3M | 34.1M | 36.5M | 35.5M | 36.9M | 34.3M |
| 存貨 | 47.3M | 49.7M | 49.3M | 52.2M | 55.8M | 59.4M | 61.4M | 61.6M | 55.8M | 48.3M | 44.5M | 47.7M |
| 總資產 | 242M | 249M | 277M | 289M | 301M | 276M | 293M | 315M | 346M | 308M | 334M | 363M |
| 有息負債 | 97.6M | 96.9M | 95.5M | 94.8M | 94.1M | 197M | 197M | 197M | 197M | 96.8M | 96.6M | 96.5M |
| 總負債 | 146M | 138M | 135M | 134M | 131M | 249M | 245M | 246M | 253M | 155M | 151M | 146M |
| 股東權益 | 96.3M | 112M | 142M | 155M | 170M | 26.8M | 47.8M | 68.6M | 93.2M | 152M | 183M | 216M |
| 負債比 | 60.3% | 55.2% | 48.7% | 46.4% | 43.6% | 90.3% | 83.7% | 78.2% | 73.1% | 50.6% | 45.2% | 40.4% |
| 淨現金(現金 − 有息負債) | −62.6M | −66.4M | −59.1M | −55.3M | −18.2M | −73.4M | −164M | −159M | −165M | −60.5M | −60.2M | −60.1M |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −12.8M | – | – | −25.7M-44% | – | – | – | −45.9M | – | – | −44.8M |
| 資本支出 | – | 65K | – | – | 123K | – | – | – | 354K | – | – | 810K |
| 自由現金流 | – | −12.9M | – | – | −25.8M-44% | – | – | – | −46.3M | – | – | −45.6M |
| 折舊攤銷 | – | 795K | – | – | 1.3M | – | – | – | 1.5M | – | – | 1.4M |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | -46.3% | – | – | -86.7% | – | – | – | -164.3% | – | – | -136.2% |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
產品／服務2025 年度 · 119M
| Consumables Product | 54.1M | 45.3% | +5.7% |
|---|---|---|---|
| Service And Other Revenue | 34.7M | 29.0% | +6.0% |
| Consoles Product | 30.7M | 25.7% | +3.0% |
| 產品 小計 | 84.8M | 71.0% | +4.7% |
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 119M | +5.1% | −81.7M | -68.3% | -5.37 | −47.1M |
| FY2024 | 114M | -12.8% | −128M | -112.6% | -36.96 | −117M |
| FY2023 | 130M | +13.0% | −173M | -132.5% | -52.28 | −135M |
| FY2022 | 115M | +12.4% | −163M | -141.2% | -3.38 | −154M |
| FY2021 | 103M | +105.5% | −132M | -128.6% | -2.89 | −133M |
| FY2020 | 49.9M | +231.2% | −121M | -243.3% | -4.85 | −108M |
| FY2019 | 15.1M | +651.3% | −68.3M | -453.0% | -99.58 | −73.6M |
| FY2018 | 2.0M | – | −49.8M | -2,480.3% | -100.75 | −48.2M |